Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves
- PMID: 7509246
- DOI: 10.1164/ajrccm.149.1.7509246
Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves
Abstract
The beta 2-adrenergic agonist formoterol has been shown to inhibit plasma extravasation in the respiratory mucosa associated with neurogenic inflammation as well as that caused by histamine or bradykinin. It is unknown whether these effects of formoterol are mediated through an action of sensory nerves or through a direct effect on the leaky blood vessels. In the present study we sought to determine whether capsaicin-sensitive sensory nerves are essential for the anti-edema effect of formoterol in the rat trachea. Substance P (5 micrograms/kg), PAF (hexadecyl-PAF, 5 micrograms/kg), or bradykinin (10 mg/kg) was injected intravenously to increase vascular permeability. The amount of plasma extravasation was measured with two tracers, Evans blue dye and Monastral blue pigment. The effectiveness of formoterol's anti-edema action was assessed in two groups of rats. One was pretreated with capsaicin to eliminate tachykinin-containing sensory nerves and another, the control group, was not pretreated. We found that in control rats formoterol inhibited to a similar extent the extravasation of Evans blue and Monastral blue caused by all three mediators. The highest intravenous dose of formoterol (10 micrograms/kg) reduced substance P-induced extravasation of Monastral blue by 59%, reduced PAF-induced extravasation by 74%, and reduced bradykinin-induced extravasation by 58%. Pretreatment of rats with a dose of capsaicin that eliminated at least 94% of the substance P-immunoreactive nerve fibers did not significantly reduce the effectiveness of formoterol against any of the mediators.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.J Pharmacol Exp Ther. 1993 Jul;266(1):270-3. J Pharmacol Exp Ther. 1993. PMID: 7687291
-
The beta 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation.Am J Physiol. 1994 Apr;266(4 Pt 1):L461-8. doi: 10.1152/ajplung.1994.266.4.L461. Am J Physiol. 1994. PMID: 7513964
-
Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol.J Appl Physiol (1985). 1994 Jul;77(1):397-405. doi: 10.1152/jappl.1994.77.1.397. J Appl Physiol (1985). 1994. PMID: 7525529
-
Infections intensify neurogenic plasma extravasation in the airway mucosa.Am Rev Respir Dis. 1992 Nov;146(5 Pt 2):S40-4. doi: 10.1164/ajrccm/146.5_Pt_2.S40. Am Rev Respir Dis. 1992. PMID: 1443906 Review.
-
Neurogenic inflammation. A model for studying efferent actions of sensory nerves.Adv Exp Med Biol. 1996;410:453-62. Adv Exp Med Biol. 1996. PMID: 9030340 Review.
Cited by
-
The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo.Br J Pharmacol. 1995 Sep;116(1):1571-6. doi: 10.1111/j.1476-5381.1995.tb16374.x. Br J Pharmacol. 1995. PMID: 8564220 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical